Immunology Companies

108 companies | Immune system disorders and autoimmune diseases

#	COMPANY	TYPE	STAGE
1.	4D Pharma plc Leeds, United Kingdom	Biotech	Preclinical to Phase II (at time of administration)	VIEW
2.	Affitech Copenhagen, Denmark (with R&D in Oslo, Norway and San Francisco, USA)	Biotech	Clinical	VIEW
3.	Agostino Gemelli University Hospital Rome, Italy	CRO	Phase 1-4	VIEW
4.	Almac Group Craigavon, United Kingdom	CDMO	Discovery	VIEW
5.	Altasciences Laval, Quebec, Canada	CRO	Preclinical to Phase II (early-phase development)	VIEW
6.	Amgen Thousand Oaks, California, United States	Pharma	Discovery through Commercial	VIEW
7.	Anthem Biosciences Bangalore, India	CDMO	Commercial	VIEW
8.	AskGene Camarillo, California, United States	Biotech	Phase 3	VIEW
9.	Astellas Pharma Inc. Tokyo, Japan	Pharma	Discovery to Phase 3	VIEW
10.	Autolus Therapeutics London, United Kingdom	Biotech	Commercial + Phase 1/2	VIEW
11.	BASF Ludwigshafen, Germany	Pharma	Commercial	VIEW
12.	Bayer Leverkusen, Germany	Pharma	Discovery through Commercial	VIEW
13.	BenevolentAI London, United Kingdom	Biotech	Phase 1\|Phase 2\|Preclinical	VIEW
14.	BioMed Valley Discoveries Kansas City, Missouri, USA	Biotech	Clinical (Phase 1-2)	VIEW
15.	Biocon Limited Bengaluru, India	Pharma	Commercial, Phase 3, Phase 2, Phase 1	VIEW
16.	Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt)	Pharma	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
17.	Bristol Myers Squibb Princeton, New Jersey, United States	Pharma	Phase 1-3 and Commercial	VIEW
18.	CARE2DATA Chennai, India	Digital Health	Commercial	VIEW
19.	CDR-Life Schlieren, Zurich, Switzerland	Biotech	Phase 1	VIEW
20.	CEMKA Bourg-la-Reine, France	CRO	Commercial	VIEW
21.	CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland	Biotech	Phase 3	VIEW
22.	CSL Limited (CSL Behring is the largest division) Melbourne, Australia (corporate); King of Prussia, USA (CSL Behring)	Pharma	Phase 1 through Commercial	VIEW
23.	Cadence Design Systems San Jose, USA	Digital Health	Commercial	VIEW
24.	Calico Life Sciences South San Francisco, United States	Biotech	Phase 2	VIEW
25.	Cantargia AB Lund, Sweden	Biotech	Phase 1 - Phase 2	VIEW
26.	Carelon Research Wilmington, Delaware, USA	CRO	Commercial	VIEW
27.	Celltrion Incheon, South Korea	Pharma	Commercial	VIEW
28.	Centrexion Therapeutics Boston, Massachusetts, United States	Biotech	Phase 1-3	VIEW
29.	Cerebras Systems Sunnyvale, USA	Digital Health	Commercial	VIEW
30.	Chiba University Chiba, Japan	Biotech	Phase 2	VIEW
31.	China Medical University Hospital (CMUH) Taichung, Taiwan	Biotech	Phase 2	VIEW
32.	Chugai Pharma Taiwan Ltd. Taipei, Taiwan	Pharma	Commercial	VIEW
33.	Chung-Ang University Seoul, South Korea	Biotech	Phase 3	VIEW
34.	Cincinnati Children's Hospital Medical Center Cincinnati, USA	Biotech	Commercial	VIEW
35.	Circio Holding ASA Lysaker, Norway	Biotech	Phase 1/2	VIEW
36.	Clinical Horizons Research Inc. Leonia, New Jersey, USA	CRO	Commercial	VIEW
37.	Crixmor LLC Malvern, Pennsylvania, USA	Biotech	Discovery	VIEW
38.	Cugene Inc. Waltham, USA	Biotech	Phase 1	VIEW
39.	CuraVac Rixensart, Belgium	Biotech	Phase 1B (completed) \| Phase 2 (in preparation)	VIEW
40.	Curadev Pharma Pvt Ltd Noida, India	Biotech	Phase 1	VIEW
41.	Cytel Cambridge, MA, USA	CRO	Service Provider	VIEW
42.	Cytel Cambridge, Massachusetts, USA	CRO	N/A - Service Provider	VIEW
43.	Cytiva Marlborough, Massachusetts, USA	MedTech	Commercial	VIEW
44.	CytoAgents Pittsburgh, USA	Biotech	Phase 2	VIEW
45.	CytoDyn Inc Vancouver, Washington	Biotech	Phase 2 clinical	VIEW
46.	CytoImmune Therapeutics Duarte, USA	Biotech	Phase 1	VIEW
47.	CytoSen Therapeutics Orlando (Winter Springs), Florida, USA	Biotech	Phase 2	VIEW
48.	Cytonics Corporation Jupiter, Florida, USA	Biotech	Phase 2	VIEW
49.	Cytonus Therapeutics Carlsbad, California, United States	Biotech	Phase 1	VIEW
50.	Cytovia Therapeutics Aventura, Florida, USA	Biotech	Phase 1/2	VIEW
51.	Daiichi Sankyo Chuo, Tokyo, Japan	Pharma	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
52.	ELIQUENT Life Sciences Washington, DC, USA	CRO	Commercial	VIEW
53.	EY Global Delivery Services (GDS) London, United Kingdom	CRO	Late Stage	VIEW
54.	Eli Lilly and Company Indianapolis, Indiana, USA	Pharma	Phase 1-Phase 3 and Commercial	VIEW
55.	Evernorth Health Services St. Louis, USA	Digital Health	Commercial	VIEW
56.	Export-Import Bank of Korea Seoul, South Korea	Pharma	Commercial	VIEW
57.	Farmindustria Rome, Italy	Pharma	Commercial	VIEW
58.	Formycon AG Planegg-Martinsried, Germany	Biotech	Commercial	VIEW
59.	Fusion Antibodies Belfast, Northern Ireland, United Kingdom	CRO	Discovery\|Preclinical\|Clinical (clients' projects)	VIEW
60.	Genentech South San Francisco, California, United States	Biotech	Discovery through Commercial	VIEW
61.	Gilead Sciences Foster City, California, United States	Pharma	Commercial	VIEW
62.	HBM Partners Zug, Switzerland	Biotech	Commercial	VIEW
63.	HCLTech Noida, India	CRO	Commercial	VIEW
64.	HDS Formación Barcelona, Spain	Digital Health	Commercial	VIEW
65.	ICLOS-PDLC L'Hospitalet de Llobregat (Barcelona), Spain	CRO	N/A (Service Provider)	VIEW
66.	IQVIA Durham, North Carolina, United States (Primary) / Danbury, Connecticut, United States (Secondary)	CRO	N/A - Service Provider	VIEW
67.	Inttl Advocare New Delhi, India	CRO	Commercial	VIEW
68.	Ionis Pharmaceuticals, Inc. Carlsbad, California, United States	Biotech	Phase 1 through Commercial	VIEW
69.	JOINN Laboratories Beijing, China	CRO	Commercial	VIEW
70.	Janux Therapeutics San Diego, California, USA	Biotech	Phase 1	VIEW
71.	Johnson & Johnson New Brunswick, New Jersey, USA	Pharma	Discovery\|Preclinical\|Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
72.	Keenova Therapeutics (formerly Endo Pharmaceuticals/Mallinckrodt Specialty Brands) Dublin, Ireland	Pharma	Commercial\|Phase 1-3	VIEW
73.	Laboratoires Servier Orléans, France	Pharma	Preclinical through Commercial	VIEW
74.	Life Science Strategy Group Menlo Park, USA	CRO	Commercial	VIEW
75.	Lifespan (now Brown University Health) Providence, USA	Pharma	Commercial	VIEW
76.	Lonza Basel, Switzerland	CDMO	Commercial	VIEW
77.	MSD Rahway, New Jersey, USA	Pharma	Commercial	VIEW
78.	Medac GmbH Wedel, Germany	Biotech	Commercial/Phase 3	VIEW
79.	Medac Pharm / medac GmbH Wedel, Germany (near Hamburg)	Pharma	Commercial\|Phase 2\|Preclinical	VIEW
80.	Merck & Co., Inc. Rahway, New Jersey, United States	Pharma	Phase 1-Phase 3 and Commercial	VIEW
81.	NPDK Bioconsulting San Diego, California	CRO	Commercial	VIEW
82.	Novartis Basel, Switzerland	Pharma	Phase 2, Phase 3, Commercial	VIEW
83.	ONO PHARMA UK LTD London, United Kingdom	Pharma	Phase 1 through Commercial	VIEW
84.	ONO Pharmaceutical Osaka, Japan (Chuo-ku)	Pharma	Phase 1-Phase 3	VIEW
85.	Otsuka Pharmaceutical Chiyoda, Tokyo, Japan	Pharma	Phase 1 through Commercial	VIEW
86.	Parexel Raleigh, North Carolina, USA	CRO	Phase I-IV (as a CRO, Parexel manages client pipelines, not its own)	VIEW
87.	Policlinico Gemelli Rome, Italy	CRO	Commercial	VIEW
88.	Ridgeline Discovery Basel, Switzerland	Biotech	Discovery\|Preclinical\|Phase 1\|Phase 2	VIEW
89.	Roche Basel, Switzerland	Pharma	Discovery\|Preclinical\|Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
90.	Sanofi Paris, France	Pharma	Preclinical through Phase 3	VIEW
91.	Scenic Biotech Amsterdam, The Netherlands	Biotech	Preclinical to IND-enabling	VIEW
92.	Senti Biosciences South San Francisco, California, USA	Biotech	Phase 1	VIEW
93.	Shanghai Jeyou Pharmaceutical Co., Ltd. Shanghai, China (Pudong district)	Biotech	Preclinical to Phase 2	VIEW
94.	Syneos Health Morrisville, North Carolina, USA	CRO	Not applicable - Syneos Health supports client pipelines across all stages (Discovery to Commercial)	VIEW
95.	TRG Ventures Hellerup, Denmark	Biotech	Phase 3	VIEW
96.	TYG Oncology Mansfield, Nottinghamshire, United Kingdom	Biotech	Phase 1	VIEW
97.	Takeda Pharmaceutical Company Tokyo, Japan	Pharma	Phase 3	VIEW
98.	Thermo Fisher Scientific Waltham, Massachusetts, United States	CRO	Full spectrum - from drug discovery through Phase I-III and commercial	VIEW
99.	U.S. Stem Cell, Inc. Sunrise, Florida, United States	Biotech	Clinical Development	VIEW
100.	University of California, Berkeley Berkeley, USA	Biotech	Discovery	VIEW
101.	University of Cincinnati Cincinnati, USA	Biotech	Commercial	VIEW
102.	University of Colorado Boulder Boulder, USA	Biotech	Discovery	VIEW
103.	University of Wisconsin–Madison Madison, USA	Biotech	Commercial	VIEW
104.	Vaxcyte San Carlos, California, USA	Biotech	Clinical (Phase 2 and Phase 3)	VIEW
105.	Viatris Canonsburg, Pennsylvania, United States	Pharma	Phase 1 to Commercial	VIEW
106.	Yasham Specialty Ingredients Pvt Ltd Mumbai, India	CDMO	Commercial	VIEW
107.	Zydus Lifesciences Limited Ahmedabad, India	Pharma	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
108.	arGenX (argenx) Amsterdam, Netherlands	Biotech	Phase 1 through Commercial	VIEW